Bath & Body Works (BBWI) Earnings Analysis

Bath & Body Works (BBWI) reported results in line with expectations in FY2026 on revenue of $35.9B versus the $35.4B estimate (+11.1% YoY) and EPS of $2.76. Below is the full Bath & Body Works earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Bath & Body Works (BBWI) Earnings Analysis — key stats

Next earnings dateJan 30, 2025
Latest reported quarterFY2026
Earnings verdictIn line
Revenue$35.9B (vs $35.4B est · +1.4% surprise · +11.1% YoY)
EPS$2.76 (vs $2.80 est · -1.4% surprise · +30.2% YoY)
Share price$292.25 (-3.5%)
Market cap$1.29T

What you'll find

Frequently asked questions

When is Bath & Body Works's next earnings date?
Bath & Body Works's (BBWI) next scheduled earnings date is Jan 30, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Bath & Body Works (BBWI) beat or miss earnings?
In FY2026, Bath & Body Works (BBWI) posted in-line results — revenue of $35.9B versus the $35.4B estimate (+1.4% surprise) and EPS of $2.76 versus $2.80 expected (-1.4% surprise). Magnisto decodes every Bath & Body Works (BBWI) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Bath & Body Works (BBWI) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Bath & Body Works (BBWI), anchored to the current $292.25 share price, so you can weigh the bull, base and bear cases for Bath & Body Works side by side.
Is Bath & Body Works (BBWI) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Bath & Body Works fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.